Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*Sophie Georgin‐Lavialle, Thomas Cluzeau, T. Comont et al.|British Journal of Dermatology|2021Cited by 414
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulationOlivier Kosmider, Benjamin Terrier, Céline Posseme et al.|Nature Communications|2024Cited by 87